Inventor
LANGSTON STEVEN P
US19 patents
⚠️ This page may combine multiple inventors who share the name “LANGSTON STEVEN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILLENNIUM PHARM INC
14 patentsUS8008307B2Aug 30, 2011
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC25 citations91
US8901136B2Dec 2, 2014
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC12 citations90
US9150525B2Oct 6, 2015
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC10 citations83
US7951810B2May 31, 2011
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC16 citations83
US9290500B2Mar 22, 2016
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC10 citations82
US9458108B2Oct 4, 2016
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC3 citations72
US9695154B2Jul 4, 2017
Heteroaryl inhibitors of sumo activating enzyme
MILLENNIUM PHARM INC4 citations71
US10745404B2Aug 18, 2020
Process for the synthesis of E1 activating enzyme inhibitors
MILLENNIUM PHARM INC1 citations70
US9802938B2Oct 31, 2017
Sulfamoylating reagents
MILLENNIUM PHARM INC2 citations70
US9663525B2May 30, 2017
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC1 citations58
US9718788B2Aug 1, 2017
Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MILLENNIUM PHARM INC0 citations51
US10202389B2Feb 12, 2019
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50
US9796725B2Oct 24, 2017
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50
US10016427B2Jul 10, 2018
Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamate
MILLENNIUM PHARM INC1 citations48